Review
Sep 2026
Targeting KRAS-Mutant Lung Cancers.
KRAS biology, therapeutic advances, mechanisms of resistance, and emerging strategies that are reshaping the treatment landscape of KRAS-mutant NSCLC are comprehensively summarized.
E. Garbo, P. Scaparone, H. J. Hoe et al.
· The Journal of the National... · 0 citations